Ileitis Secondary to Oral Capecitabine Treatment?
The efficacy of capecitabine as adjuvant therapy in colon cancer is well demonstrated and its lower toxicity rates when compared with 5-FU make it an increasingly more favourable option for patients. This case highlights the awareness of a potentially severe side effect related to the use of capecit...
Saved in:
Main Authors: | Rami Radwan, Wanangwa C. Namelo, Mark Robinson, Alison E. Brewster, Gethin L. Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/154981 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma
by: Kristian Larson, et al.
Published: (2018-01-01) -
CMV Ileitis: To Treat or Not to Treat? Implications of Initiating Biologic Therapy for Concurrent Crohn’s Disease
by: Kendra T. Stilwell, et al.
Published: (2019-01-01) -
Capecitabine-induced Hand-foot Syndrome with Hyperpigmentation on Oral Mucosa and Nails: A Rare Entity
by: Suprit Malali, et al.
Published: (2025-02-01) -
Incorporation of Capecitabine Into Extended Chain of N-Acylated Chitosan Carrier
by: Anita Marlina, et al.
Published: (2024-01-01) -
A 5-Fluorouracil-Induced Hyperammonemic Encephalopathy Challenged with Capecitabine
by: Michael Chahin, et al.
Published: (2020-01-01)